Targeting IL-6 trans-signalling: past, present and future prospects
S Rose-John, BJ Jenkins, C Garbers, JM Moll… - Nature Reviews …, 2023 - nature.com
Abstract Interleukin-6 (IL-6) is a key immunomodulatory cytokine that affects the
pathogenesis of diverse diseases, including autoimmune diseases, chronic inflammatory …
pathogenesis of diverse diseases, including autoimmune diseases, chronic inflammatory …
Interleukin-6 family cytokines
S Rose-John - Cold Spring Harbor perspectives in …, 2018 - cshperspectives.cshlp.org
The interleukin (IL)-6 family cytokines is a group of cytokines consisting of IL-6, IL-11, ciliary
neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM) …
neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM) …
The role of IL-6 in host defence against infections: immunobiology and clinical implications
S Rose-John, K Winthrop, L Calabrese - Nature Reviews Rheumatology, 2017 - nature.com
IL-6 is a pleiotropic cytokine with broad-ranging effects within the integrated immune
response. One of the roles of IL-6 is to support immunocompetence, defined as the ability of …
response. One of the roles of IL-6 is to support immunocompetence, defined as the ability of …
[HTML][HTML] The shedding protease ADAM17: Physiology and pathophysiology
F Zunke, S Rose-John - Biochimica et Biophysica Acta (BBA)-Molecular …, 2017 - Elsevier
The disintegrin metalloprotease ADAM17 has been a matter of intense studies aiming to
unravel structure, function and regulation of protease expression, maturation and activity. In …
unravel structure, function and regulation of protease expression, maturation and activity. In …
Cell death in the lung: the apoptosis–necroptosis axis
Regulated cell death is a major mechanism to eliminate damaged, infected, or superfluous
cells. Previously, apoptosis was thought to be the only regulated cell death mechanism; …
cells. Previously, apoptosis was thought to be the only regulated cell death mechanism; …
Therapeutic targeting of IL-6 trans-signaling
S Rose-John - Cytokine, 2021 - Elsevier
Abstract Interleukin-6 (IL-6) is a cytokine, which is involved in innate and acquired immunity,
in neural cell maintenance and in metabolism. IL-6 can be synthesized by many different …
in neural cell maintenance and in metabolism. IL-6 can be synthesized by many different …
The soluble interleukin 6 receptor: advanced therapeutic options in inflammation
S Rose‐John - Clinical Pharmacology & Therapeutics, 2017 - Wiley Online Library
Interleukin (IL)‐6 binds to IL‐6R and the complex of IL‐6 and IL‐6R associates with the
receptor subunit gp130, which initiates signaling. gp130 is expressed on all cells. IL‐6R is …
receptor subunit gp130, which initiates signaling. gp130 is expressed on all cells. IL‐6R is …
Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia
D Hirani, CM Alvira, S Danopoulos… - European …, 2022 - Eur Respiratory Soc
Rationale Premature infants exposed to oxygen are at risk for bronchopulmonary dysplasia
(BPD), which is characterised by lung growth arrest. Inflammation is important, but the …
(BPD), which is characterised by lung growth arrest. Inflammation is important, but the …
ADAM17 activity and IL-6 trans-signaling in inflammation and cancer
N Schumacher, S Rose-John - Cancers, 2019 - mdpi.com
All ligands of the epidermal growth factor receptor (EGF-R) are transmembrane proteins,
which need to be proteolytically cleaved in order to be systemically active. The major …
which need to be proteolytically cleaved in order to be systemically active. The major …
ADAM17: an emerging therapeutic target for lung cancer
MI Saad, S Rose-John, BJ Jenkins - Cancers, 2019 - mdpi.com
Lung cancer is the leading cause of cancer-related mortality, which histologically is
classified into small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) …
classified into small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) …